Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Argus Research Downgrades Tyson Foods to Hold

Argus Research Downgrades Tyson Foods to Hold

Argus Research analyst John Staszak downgrades Tyson Foods (NYSE:TSN) from Buy to Hold.

byBenzinga Newsdesk

September 13, 2022

1 minute read

Argus Research analyst John Staszak downgrades Tyson Foods (NYSE:TSN) from Buy to Hold.

Elon Musk Isn’t The First: Disney ‘Almost’ Bought Twitter Until Bob Iger Noticed These Red Flags

By Shanthi Rexaline

September 8, 4:13 AM

As Tesla Inc. (NASDAQ: TSLA) Elon Musk fights a legal battle to steer clear of the deal with Twitter, Inc.

DIS

General Dynamics Bags ~$273M US Navy Contract

By Akanksha Bakshi

July 20, 12:48 PM

General Dynamics Corp (NYSE:GD) business unit General Dynamics Mission Systems has secured a $272.9 million U.S. Navy contract to support the…

Jaguar Health To Present Phase 3 OnTarget Trial Results For Its Cancer Supportive Care Drug Crofelemer On Or Before July 23, 2024

By Benzinga Newsdesk

June 12, 8:38 AM

Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates, and leading oncology experts on cancer

JAGX

Why Entrada Therapeutics Stock Is Diving After Hours

By Adam Eckert

December 19, 5:49 PM

Entrada Therapeutics Inc (NASDAQ: TRDA) shares are trading lower in Monday's after-hours session after the company said it received a clinical hold notice from the

TRDA

Argus Research Downgrades Tyson Foods to Hold

Related Posts

Elon Musk Isn’t The First: Disney ‘Almost’ Bought Twitter Until Bob Iger Noticed These Red Flags

General Dynamics Bags ~$273M US Navy Contract

Jaguar Health To Present Phase 3 OnTarget Trial Results For Its Cancer Supportive Care Drug Crofelemer On Or Before July 23, 2024

Why Entrada Therapeutics Stock Is Diving After Hours